Wednesday, February 19, 2020

BOOK  PROFITS IN  MY PHARMA COMPANIES RECOMMANDED ON NOVEMBER 26 2019

DIVISLAB  1650>>>>>>>2100(BOOK  PROFITS)

IPCALAB 950>>>>>>>>>1500(BOOK PROFITS)

JBCHEM 380>>>>>>>>>575    (BOOK PROFITS)

ASTRAZEN  2500>>>>>>2939         (HOLD.....)

 FOR  ORIGINAL POST CLICK  HERE. https://valuestocks4u.blogspot.com/2019/11/after-long-period-of-consolidation-mid.html




Sunday, January 12, 2020

FDC


A SMALL CAP  PHARMACEUTICAL  COMPANY LOOKING  HOT  ON  CARDS.

BUY @210-205  LEVEL  FOR  THE  TARGET  OF 310.

VIRTUALLY  A DEBT  FREE  COMPANY  HAVING 3737 CR MARKET  

CAPITALIZATION.

TRADING @ PE  OF 19.5,PROMOTERS  HAVING  MORE  THAN 69.5%  SHARE 

HOLDING  IN THIS  COMPANY. 



Tuesday, January 7, 2020

MCX

Image result for mcx logo

A  candidate  for long  term  play..........beneficial  candidate for  sebi's  margin policy implementation.  buy@1200-1215  level  tgt 7000.

Thursday, January 2, 2020


                        PARTIAL BOOK  PROFITS  IN GUJRAT GAS LTD@270


Gujratgas recommanded @190 on nov 4 it  touched 270 today book  partial profit with 40% return in just 2  months..... the original post  link  given  below 

Monday, December 30, 2019

BALRAMPUR CHINNI -SWEET  TIME AHEAD

Image result for BALRAMCHINNI LOGO


BUY@170-174  LEVEL 138  STOP LOSS  TGT 240

Friday, December 27, 2019

BANK NIFTY  SPOT


                                                 

                                                             


Iam  bullish  with  banknifty spot above 32200 . It  will  be trading  abv 32200  can 1200-1400  rally  from  here. If  cant  trade abv the mentioned  level the gap  of 31650-31700  will  be filled  in  coming  days...

Wednesday, December 11, 2019

Image result for jbchemical logo
A small cap  pharma company with a market cap of 3389 cr It  is  a  high  cash reserved  company.it  is  in a 3 year  breakout  

buy@402-410  levels  for  a  tgt  of 520.

mkt  cap-3389, pe 13.45

sales  improved  during 2016-2019  is 1344 cr to 1643

net profit  improved from 163 cr  to 193 cr  during 2016-2019

eps  improved  from  19.16  to  24.11  during 2016-2019.